AlliancePharma Announces Granting of Options
(firmenpresse) - THETFORD MINES, QUEBEC -- (Marketwired) -- 01/30/15 -- AlliancePharma Inc. ("Alliance" or the "Corporation") (TSX VENTURE: APA) granted an aggregate of 375,000 stock options an exercise price of $0.15 per share for a period of 5 years (the "Options") to certain directors, employees and consultants in accordance with the Corporation''s Stock Option Plan. The Option grant is subject to approval from the TSX Venture Exchange.
Pursuant to the Option grant, Mr. Michael Kinley, who was appointed a director of the Corporation on January 8, 2015, received 150,000 Options.
Mr. Kinley received his Bachelor of Commerce degree from Mount Allison University in 1971 and his Chartered Accountant designation in Ontario in 1973. He earned his designation with KPMG, where he spent 20 years (1971-1991) the last ten as a partner. During the past twenty years Mr. Kinley has served as an officer and director for a number of public companies listed on the TSX and TSX Venture Exchanges.
Mr. Kinley will bring strong expertise and knowledge in accounting and management to the Board of APA. He will surely provide a strong and solid support to the management team of the Corporation.
The Corporation shareholders approved the Stock Option Plan on October 9, 2014.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
AlliancePharma Inc.
Marc Lemieux
Chief Financial Officer
(418) 334-8767
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.01.2015 - 14:02 Uhr
Sprache: Deutsch
News-ID 1333909
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
THETFORD MINES, QUEBEC
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 296 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AlliancePharma Announces Granting of Options
"
steht unter der journalistisch-redaktionellen Verantwortung von
AlliancePharma Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
